Knoll Capital Management, LLC Diversified Active

Location: Miami, FL

CIK: 0001325083 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 14, 2019

Total Value: $122M (100.0% shares, 0.0% debt)

Holdings (22)

— Corbus Pharmaceuticals HLDGS 28.3%

Value $34.55M Shares 4,985,870 Est. Cost $4.98 Unrealized —

— Biohaven Pharmactl Hldg Co L 26.9%

Value $32.83M Shares 749,815 Est. Cost $25.00 Unrealized —

— Abeona Therapeutics Inc 9.2%

Value $11.28M Shares 2,359,767 Est. Cost $4.97 Unrealized —

— Blackstone Group LP 5.6%

Value $6.796M Shares 153,000 Est. Cost $34.97 Unrealized —

KRYS Krystal Biotech Inc 4.8%

Value $5.923M Shares 147,090 Est. Cost $10.08 Unrealized +224.3%

MO Altria Group Inc 3.5%

Value $4.262M Shares 90,000 Est. Cost $29.72 Unrealized +4.1%

— Applied Therapeutics Inc 3.2%

Value $3.849M Shares 467,071 Est. Cost $8.24 Unrealized —

— Eiger Biopharmaceuticals Inc 3.0%

Value $3.713M Shares 350,238 Est. Cost $10.44 Unrealized —

ALDX Aldeyra Therapeutics Inc 2.6%

Value $3.176M Shares 529,390 Est. Cost $8.55 Unrealized -12.0%

KBA Kraneshares TR 2.4%

Value $2.972M Shares 96,000 Est. Cost $31.89 Unrealized —

AVXL Anavex Life Sciences Corp 2.0%

Value $2.441M Shares 724,205 Est. Cost $3.56 Unrealized -12.8%

DD Dupont de Nemours Inc 1.8%

Value $2.252M Shares 30,000 Est. Cost $27.24 Unrealized 0.0%

— Galmed Pharmaceuticals Ltd 1.2%

Value $1.515M Shares 206,099 Est. Cost $11.90 Unrealized —

DOW Dow Inc 1.2%

Value $1.479M Shares 30,000 Est. Cost $36.37 Unrealized 0.0%

ENTX Entera Bio Ltd 1.2%

Value $1.474M Shares 475,540 Est. Cost $6.29 Unrealized -37.9%

— Molecular Templates 0.8%

Value $951K Shares 113,905 Est. Cost $4.04 Unrealized —

CTVA Corteva Inc 0.7%

Value $887K Shares 30,000 Est. Cost $25.02 Unrealized 0.0%

— Electrocore Inc 0.7%

Value $794K Shares 396,825 Est. Cost $16.51 Unrealized —

— Soligenix Inc. 0.5%

Value $595K Shares 837,800 Est. Cost $2.11 Unrealized —

— Catasys Inc 0.2%

Value $281K Shares 14,614 Est. Cost $19.23 Unrealized —

— Lipocine Inc New 0.1%

Value $97,000 Shares 50,000 Est. Cost $1.30 Unrealized —

— Vascular Biogenics Ltd 0.0%

Value $28,000 Shares 21,400 Est. Cost $1.31 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Corbus Pharmaceuticals HLDGS	4,985,870	$34.55M	28.3%	$4.98	—	COM	21833P103
—	Biohaven Pharmactl Hldg Co L	749,815	$32.83M	26.9%	$25.00	—	COM	G11196105
—	Abeona Therapeutics Inc	2,359,767	$11.28M	9.2%	$4.97	—	COM	00289Y107
—	Blackstone Group LP	153,000	$6.796M	5.6%	$34.97	—	COM UNIT LTD	09253U108
KRYS	Krystal Biotech Inc	147,090	$5.923M	4.8%	$10.08	+224.3%	COM	501147102
MO	Altria Group Inc	90,000	$4.262M	3.5%	$29.72	+4.1%	COM	02209S103
—	Applied Therapeutics Inc	467,071	$3.849M	3.2%	$8.24	—	COM	03828A101
—	Eiger Biopharmaceuticals Inc	350,238	$3.713M	3.0%	$10.44	—	COM	28249U105
ALDX	Aldeyra Therapeutics Inc	529,390	$3.176M	2.6%	$8.55	-12.0%	COM	01438T106
KBA	Kraneshares TR	96,000	$2.972M	2.4%	$31.89	—	BOSERA MSCI CH	500767405
AVXL	Anavex Life Sciences Corp	724,205	$2.441M	2.0%	$3.56	-12.8%	COM NEW	032797300
DD	Dupont de Nemours Inc	30,000	$2.252M	1.8%	$27.24	0.0%	COM	26614N102
—	Galmed Pharmaceuticals Ltd	206,099	$1.515M	1.2%	$11.90	—	SHS	M47238106
DOW	Dow Inc	30,000	$1.479M	1.2%	$36.37	0.0%	COM	260557103
ENTX	Entera Bio Ltd	475,540	$1.474M	1.2%	$6.29	-37.9%	SHS	M40527109
—	Molecular Templates	113,905	$951K	0.8%	$4.04	—	COM	608550109
CTVA	Corteva Inc	30,000	$887K	0.7%	$25.02	0.0%	COM	22052L104
—	Electrocore Inc	396,825	$794K	0.7%	$16.51	—	COM	28531P103
—	Soligenix Inc.	837,800	$595K	0.5%	$2.11	—	COM	834223307
—	Catasys Inc	14,614	$281K	0.2%	$19.23	—	COM PAR	149049504
—	Lipocine Inc New	50,000	$97,000	0.1%	$1.30	—	COM	53630X104
—	Vascular Biogenics Ltd	21,400	$28,000	0.0%	$1.31	—	COM	M96883109